FOXA1 and hepatocellular carcinoma: To overcome this functional redundancy, we investigated the role of Foxa1 in human hepatocytes and hepatoma cells by gain-of-function experiments and found that Foxa1 is a potent inhibitor of hepatic triglyceride (TG) synthesis and secretion.